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Molecular chaperones and protein folding catalysts are normally thought of as intracellular proteins
involved in protein folding quality control. However, in the mycobacteria there is increasing evidence to
support the hypothesis that molecular chaperones are also secreted intercellular signalling molecules or
can control actions at the cell wall or indeed control the composition of the cell wall. The most recent
evidence for protein moonlighting in the mycobacteria is the report that chaperonin 60.2 of Mycobac-
terium tuberculosis is important in the key event in tuberculosis e the entry of the bacterium into the
macrophage. This brief overview highlights the potential importance of the moonlighting functions of
molecular chaperones in the biology and pathobiology of the mycobacteria.
 2010 Elsevier Ltd. All rights reserved.The recent report1 that the molecular chaperones, chaperonin
(Cpn)60.2 (also known as Hsp65) and Hsp70 are found on the cell
surface of virulentMycobacterium tuberculosis and that the Cpn60.2
protein acts as a major adhesin for the binding of M. tuberculosis to
monocytes adds further evidence for the hypothesis that the
molecular chaperone/cell stress molecules of the mycobacteria are
vital moonlighting proteins (Box 1) acting outside of the cell to
promote bacterial survival and virulence. This extracellular func-
tionality may synergise with the intracellular cell stress respon-
siveness of these molecular chaperones to generate a novel
homeostatic network of interactions. These ﬁndings are occurring
at the same time as questions grow over the function of the Hsp60
proteins of the mycobacteria, with one recent study suggesting that
the second Cpn60 protein of M. tuberculosis (Cpn60.1) is not
a molecular chaperone.2
The identiﬁcation of antibodies in patients infected with
a variety of different bacteria gave rise to the concept of the
‘common antigen’ which was shown to be homologous to the, then,
recently discovered Escherichia coli, GroEL protein3 which was
identiﬁed as a molecular chaperone, chaperonin (Cpn)60.4 Inves-
tigations of the M. tuberculosis Cpn60.2 (Hsp65) protein led to the
discovery of its pivotal role in the control of the pathogenesis of
adjuvant arthritis in the rate a model of rheumatoid arthritis.5 This
pioneering work has been responsible for our current under-
standing, such as it is, of the potent T cell immunomodulatory. Henderson).
All rights reserved.activity of M. tuberculosis Cpn60.2.6 Curiously, 20 years after this
seminal study there are more publications on the role of
M. tuberculosis Cpn60.2 in autoimmunity than on the use of this
protein as a potential vaccine for tuberculosis.
What could account for the enormously potent immunomodu-
latory actions of M. tuberculosis Cpn60.2? The ﬁnding in 1993 that
M. tuberculosis Cpn60.2 could stimulate human peripheral blood
macrophages to secrete pro-inﬂammatory cytokines7 suggested that
this protein could induce classical activation of macrophages leading
to T and B cell activation. However, more detailed analysis of
macrophages exposed to M. tuberculosis Cpn60.2 revealed that they
did not have enhanced expression of Fcg receptors, MHC class II
proteins or produce more oxygen-derived free radicals, which are all
markers of the classically activated macrophage state.8 Classical
activation is induced by factors such as interferon (IFN)g, which is
a key factor in the host response to M. tuberculosis.9 However, it is
now recognised that macrophages can be induced to enter other
states which have been termed alternative macrophage activation
states.9 Moreover, whenM. tuberculosis Cpn60.2 was incubated with
cultured humanvascular endothelial cells, it induced the synthesis of
E-selectin, ICAM-1 and VCAM-1 by a novel, cytokine-independent,
mechanism.10 These early studies revealed novel interactions of this
mycobacterial Cpn60.2 protein with macrophages and vascular
endothelial cells which could have consequences for the pathology
of tuberculosis. For example, the ability to stimulate macrophages
into a non-classical activation state will prevent antigen-presenta-
tion and stimulation of antigen-speciﬁc CD4 T lymphocytes (with
concomitant IFN-g synthesis)e perhaps accounting for the ability of
M. tuberculosis to survivewithin themacrophage. However, thework
Box 1. Protein Moonlighting
Proteins are composed of approximately 20 amino acids. If
life consisted of proteins with only 100 residues the poten-
tial number of protein combinations is, 20100, which is
equivalent to 10130. In light of the immense potential the
evolutionary process has for producing different proteins it
is surprising to find that a growing number of proteins, in
prokaryotes and eukaryotes, have more than one function.
Such proteins are termed moonlighting proteins and it is
possible for one protein to have a range of different func-
tions.57 An interesting facet of these proteins is that
a moonlighting protein in one organism may not be
a moonlighting protein in another, suggesting that small
variations in protein sequence are responsible for these
moonlighting actions. Thus, it has been shown that the
moonlighting functions of different proteins are not
conserved between different yeast species.58 Another
example is the essential role played by murine Cpn60 in the
capacitation of sperm.59 However, human Cpn60 does not
play any role in human sperm capacitation.60 In addition to
the cell stress proteins, Mycobacterium tuberculosis has
been shown to have other moonlighting proteins such as
a glutamate racemase with DNA gyrase activity.61 The
immunodominant secreted antigen85 proteins of M.
tuberculosis turn out both to be fibronectin adhesins and
mycosyltransferases involved in mycolic acid synthesis.62
The M. tuberculosis malate synthase (the first enzyme of
the glyoxylate cycle) has also been found to be surface
located and bind to fibronectin and laminin.63 In keeping
with the moonlighting functions of metabolic enzymes, the
TCA cycle enzyme, aconitase also functions as an iron-
responsive protein responsible for posttranscriptional
regulation of the expression of proteins involved in iron
homeostasis64 and the superoxide dismutase of Mycobac-
terium avium functions as an adhesin for this bacterium.65
The most recent example is the phosphodiesterase of M.
tuberculosis which alters cell wall permeability.66 One
recent hypothesis to explain protein moonlighting is that it
is a facet of intrinsically disordered proteins.67 Is this
hypothesis is correct it may open up ways of predicting the
‘moonlight-ome’ of bacteria such as M. tuberculosis.
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Cpn60.2 could be secreted by M. tuberculosis.
This pioneering work resulted in chaperonins from other
bacteria being examined for cellecell signalling activity. One such
study identiﬁed a potent bone resorbing protein from an oral
bacterium involved in periodontitis as the Cpn60 protein of this
organism.11 Curiously, while the Cpn60 protein from E. coli (GroEL)
was also able to promote bone matrix breakdown, neither of the
Cpn60.2 proteins from M. tuberculosis or Mycobacterium leprae
were able to promote bone destruction.11 Given the marked
sequence conservation of the chaperonins, this was a completely
unexpected ﬁnding, but one that, as shall be seen, repeats itself
again and again. Further analysis of recombinant GroEL revealed
that this protein promoted bone resorption by stimulating the
formation of the multinucleate myeloid-derived cell population
known as the osteoclast, which is the cell responsible for homeo-
static bone breakdown.12 It was, by this time, known that
M. tuberculosis and M. leprae encoded two Cpn60 proteins (termed
Cpn60.1 and Cpn60.23) and it was thought that the Cpn60.1 protein
would have bone resorbing activity. However, recombinant
M. tuberculosis Cpn60.1 was also shown to be unable to stimulate
bone breakdown or osteoclast proliferation.13 In contrast, theCpn10 protein of this organism had bone destructive activity
in vitro.13 This inability of the M. tuberculosis Cpn60 proteins to
promote bone breakdown proved to be even more unusual when it
was found that human Cpn60 (Hsp60) was also a potent stimulator
of the resorption of cultured bone explants.14
While both M. tuberculosis Cpn60 proteins showed similar
inabilities to promote bone resorption and osteoclast proliferation,
comparative analysis of these two very similar proteins (with 61%
sequence identity) has begun to reveal signiﬁcant differences in
terms both of protein folding activity and extracellular signalling
capacity. Direct comparison of the human monocyte cytokine-
inducing ability of these two Cpn60 proteins showed that the
recombinant Cpn60.1 protein was both more potent and more
efﬁcacious than the Cpn60.2 protein.15 The monocyte cytokine-
inducing activity of Cpn60.1 could be blocked by a neutralising
anti-CD14 monoclonal. This was not true of Cpn60.2.15 Now this
neutralising activity does not mean that Cpn60.1 binds to CD14, but
only that CD14 is part of some, as yet, undiscovered receptor
complex through which Cpn60.1 signals. Afﬁnity proteomic anal-
ysis of the human monocyte proteins that bound toM. tuberculosis
Cpn60.1 failed to identify CD14 as a cognate ligand.16 A key question
arose e what is the active Cpn60 protein e is it the oligomer, the
monomer or does activity reside in some constituent sequence of
the monomer. The three individual domains (equatorial, axial and
apical) ofM. tuberculosis Cpn60.1were cloned and expressed and all
monocyte cytokine stimulating activity was found to reside in the
equatorial domain.17
The cell signalling activities of the M. tuberculosis Cpn60
proteins have been derived from in vitro experiments which might
be viewed as artefactual. However, there is now evidence emerging
for the moonlighting actions of these proteins being important in
the living animal and for major differences to exist between Cpn60
proteins from different species. Thus administration of the Cpn60
proteins fromM. tuberculosis, M. leprae, bacillus Calmette-Guérin (all
Cpn60.2 proteins),Streptococcus pneumoniae, or Helicobacter pylori
to mice with developing experimental allergic asthma revealed
that only the M. leprae Cpn60.2 protein was able to block the signs
and symptoms of asthma including the inhibition of local inﬂam-
mation and of bronchial hyperreactivity.18 Using the identical
model to compare the effect of acute administration of M. tuber-
culosis Cpn60.1, Cpn60.2 or Cpn10 the results concurred with the
earlier study in respect of the lack of activity of the Cpn60.2 protein.
However, low doses of Cpn60.1 were able to block both lung
inﬂammation and bronchial hyperreactivity.19 The Cpn10 protein
also had some inhibitory activity but less than the Cpn60.1
protein.19 The surprising aspect of this ﬁnding is that the M.
tuberculosis and M. leprae Cpn60.2 proteins exhibit around 95%
sequence identity. For most bioinformaticists these would be the
same protein. Yet as far as the mouse is concerned it sees two very
different biological signals in these Cpn60.2 proteinse onewhich is
potently anti-inﬂammatory and one that is not.
Thus far the writing has suggested that secreted molecular
chaperones are pro-inﬂammatory, cell activating, proteins.
However, this is not the case and more molecular chaperones show
anti-inﬂammatory actions than pro-inﬂammatory activity.20 More
detailed analysis of the effect of the M. tuberculosis Cpn60 proteins
on bone and bone cells has revealed that the Cpn60.2 protein has
no positive or negative effects on bone remodelling dynamics. In
contrast, recombinant Cpn60.1 is a potent inhibitor of agonist-
induced bone resorption and osteoclast proliferation in vitro. The
activity of this protein is uniquely long-lived and appears to func-
tion, at least over the ﬁrst few days of interaction, by blocking
transcription of the major osteoclast transcription factor NFATc1.21
Administration of Cpn60.1 also completely blocks the massive
osteoclastic bone destruction seen in the joints of rats with
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occurs without any diminution of joint inﬂammation.21 This is the
same proﬁle of activity induced by the natural inhibitor of osteo-
clast differentiation, osteoprotegerin (OPG) in the adjuvant
model.22 However, the M. tuberculosis Cpn60.1 protein does not
induce the synthesis of OPG and has no sequence homology to OPG.
It must therefore be classiﬁed as a bacterial OPG mimic (or vice
versa) e a very unusual ﬁnding in bacteriology. In this study it was
also shown that M. tuberculosis Cpn60.1 is present in the blood of
patients with tuberculosis.21
Another example of the inhibitory actions of M. tuberculosis
Cpn60.1 is its effect on the biological activity of puriﬁed protein
derivative (PPD) an admixture of pro-inﬂammatory mycobacterial
components. It is known that responsiveness to this material is
suppressed in tuberculosis. It has been reported thatM. tuberculosis
Cpn60.1 inhibits PPD-induced expression of IL-12P40 by macro-
phages via a mechanism involving induction of TLR2 and binding
of the Cpn60.1 protein to this pattern recognition receptor to
downregulate nuclear c-rel and, in consequence, block IL-12P40
transcription.23
To explore more fully the role of theM. tuberculosis chaperonins,
attempts were made to inactivate each of the three genes. It proved
impossible to inactivate the chromosomal copies of cpn60.2 or
cpn10 unless plasmid-encoded copies were supplied, suggesting
that these genes are essential. However, the cpn60.1 gene could be
inactivated (in the virulent strain H37Rv) without obvious pheno-
type and the isogenic mutant responded to a wide variety of
stresses in an identical manner to the wild type organism.2
However, when the Dcpn60.1 isogenic mutant was used to infect
mice and guinea pigs it failed to generate a granulomatous
response.2 The complemented strain gave an in vivo response
identical to the wild type organism showing that the effect of gene
inactivation is not due to polar effects. It had previously been
reported that the M. tuberculosis Cpn60 proteins did not have the
classic tetradecameric structure of the prototypic E. coli GroEL24
and the crystal structure of the Cpn60.2 protein was not a tetrade-
camer but a dimer.25 This raised questions about the role of these
mycobacterial proteins as molecular chaperones. Using a cpn60/
cpn10 (groEL/groES) conditional mutant to determine complemen-
tation it was found that the cpn60.2 and cpn10 genes could
complement this E. colimutant.2 However, and this is an important
ﬁnding, the cpn60.1 genewould not complement. This suggests that
the cpn60.1 gene has evolved to lose its protein folding activity but
gain the activity proﬁle of a myeloid cell-modulating mediator able
to inhibit osteoclast production but promote giant cell/granuloma
formation. The development of non-folding actions has recently
been suggested to be the evolutionary fate of all the extra cpn60
genes found in bacteria.4
Is this ﬁnding with the Cpn60.1 protein of M. tuberculosis just
a ‘one off’? The answer is no, as it has been reported that inacti-
vation of the cpn60.1 gene in Mycobacterium smegmatis results in
a mutant that grows normally in planktonic culture but which fail
to form bioﬁlms. This is due to the association of Cpn60.1 with
KsaA, a protein involved in the type II fatty acid synthase which
generates cell surface mycolic acids. To generate bioﬁlms, the
bacterium must produce elevated levels of short-chain fatty acids
and failure to do so results in altered cell surface properties and an
inability to form a bioﬁlm.26 As the reader may have begun to
expect, when it comes to protein moonlighting, the inactivation of
the cpn60.1 gene in M. tuberculosis does not alter mycolic acid
synthesis or the ability to form bioﬁlms.2 Surprise-follows-surprise
inmoonlighting, with the recent report thatM. tuberculosis Cpn60.1
binds to DNA with high afﬁnity but with low speciﬁcity. Such
binding is protective of the DNA when it is exposed to DNase I or
hydroxyl radicals.27 However, such binding obviously is notessential for survival as the cpn60.1 gene can be inactivated without
obvious phenotype in culture.2
The function of the 10 kDa mycobacterial Cpn10 protein is less
clear. Initial studies of the monocyte activating capacity of a variety
of M. tuberculosis molecular chaperones suggested the only one
without activity was Cpn10.28 This suggests the possibility that this
Cpn10 protein has anti-inﬂammatory properties. Two studies have
shown that M. tuberculosis Cpn10, when administered acutely, can
inhibit the severity of adjuvant arthritis in the rat.29,30 In such
experiments, the Cpn10 is acting as a direct modulator of leukocyte,
or other cell population, function and not as a vaccine. These
studies support the more recent ﬁndings with human recombinant
Cpn10, which is currently in clinical trial as a therapeutic agent for
inﬂammatory diseases such as rheumatoid arthritis.31
Thus a picture is emerging of a moonlighting landscape for the
mycobacterial chaperonins, particularly the Cpn60 proteins, with
a growing range of biological actions being ascribed to these
proteins which appear to be linked to the virulence of M. tubercu-
losis (Figure1).
Small heat shock proteins, which are cytoplasmic proteins of
molecular mass 10e20 kDa32, and have a range of nomenclature
in mycobacteria (alpha (a) crystallin, hspX (Acr1 e Rv2031c),
Acr2 e Rv0251c), also appear to have moonlighting functions. The
a-crystallins are large polydisperse oligomers of two isoforms,
aA- and aB-crystallins whose function is to prevent protein
aggregation and to disaggregate protein aggregates.
An early ﬁndingwas the identiﬁcation of a-crystallin as themajor
membrane protein in the virulent Erdman strain ofM. tuberculosis.33
A later study revealed that M. tuberculosis and Mycobacterium bovis,
if grown under low oxygen conditions, which can induce dormancy,
increased the thickness of their cell walls and these cell walls con-
tained large amounts of a-crystallin. It is unclear what this small heat
shock protein is doing within the cell wall. It may be functioning to
prevent protein misfolding in the cell wall milieu or possibly it is
having some unexpected moonlighting function.34
If a-crystallin (Acr1) is a molecular chaperone then inactivation
of the gene coding for this protein would be assumed to affect cell
behaviour, particularly cell growth. Unexpectedly, an unmarked
deletion of acr1 inM. tuberculosis resulted in signiﬁcant increases in
the rate of cell division in both infected macrophages and mice35,
suggesting this protein is, somehow, involved in the control of cell
division rate. As a corollary, overexpression of the acr1 gene from
the strong cpn60 promoter resulted in reductions in the growth
rates of bothM. smegmatis andM. tuberculosis.36 It should be noted
that upregulation of Acr1 can occur with merely standing in
culture or as a result of centrifugation.37 The other a-crystallin-like
protein, Acr2 also has unusual behaviour. Within 1 h of infection
of monocytes/macrophages there is increased expression of
M. tuberculosis Acr2 reaching a peak of 18e55efold within 24 h.38
This is one of the most induced proteins in M. tuberculosis and
also one of the most immunogenic e possibly suggesting release
from cells in vivo. However, the acr2 gene can be inactivated
without any in vitro phenotype38 and the only change in vivo is
a slowing of disease progression, possibly as a result of diminished
recruitment of leukocytes to the infected lungs.39 These ﬁndings
suggest that Acr1 and Acr2 should be studied for additional
moonlighting functions.
The ﬁnal mycobacterial molecular chaperone found to have
moonlighting actions is the Hsp70 (DnaK) protein. In the human,
there are many Hsp70 proteins and it is emerging that they have
a range of intracellular functions40 as well as extracellular moon-
lighting functions.20 However, much less is known about the
moonlighting functions of bacterial Hsp70 proteins. There is growing
evidence that the generation of CC and CXC chemokines in tuber-
culosis drives the process of granuloma formation and may be an
Mycobacterium tuberculosis
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Figure 1. A summary of the moonlighting actions of the mycobacterial molecular chaperones (Ml e Mycobacterium leprae, Mtb e Mycobacterium tuberculosis).
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has been little work done to establish the factors in M. tuberculosis
that drive granuloma formation. The ﬁnding that recombinant
M. tuberculosis Hsp70 dose-dependently stimulated CD8-enriched
T cells from naive non-human primates to secrete the CC chemo-
kines: CCL3 (Mip1a), CCL4 (Mip1b) and CCL5 (RANTES) was there-
fore both unexpected and of signiﬁcant interest.42 Of importance for
a later part of this article is the fact that CCL4 and CCL5 bind to the
chemokine receptor CCR5. The human Hsp70 protein was reported
to bind to the toll-like receptors (TLR)2 and TLR4.43 However,
a detailed study of the binding ofM. tuberculosis Hsp70 to a number
of monocytic and dendritic cells and cell lines revealed that the
induction of the formation of the above CC chemokines required the
binding of Hsp70 to CD40, a tumour necrosis factor receptor super-
family member.44 Various controls excluded that chemokine
synthesis was due to LPS contamination44 and this ﬁnding supports
the hypothesis that M. tuberculosis Hsp70 is a major inducer of CC
chemokines required for granuloma formation. In an entirely sepa-
rate study, it was found that CD40/ mice were extremely suscep-
tible to aerosolised infection byM. tuberculosis and that this was due
to inadequate priming of interferon (IFN)g-producing T cells conse-
quent on a failure to secrete sufﬁcient IL-12. Unexpectedly, CD40L/
mice were resistant to infection with M. tuberculosis, suggesting an
alternative ligand was interacting with CD40. It was shown that
M. tuberculosis Hsp70 was such an alternative CD40 ligand in these
infected mice.45 The CD40 binding active site in M. tuberculosis
Hsp70 is within the C-terminus.46 This distinguishes this protein
from human Hsp70 whose biologically active site is within the
N-terminal ATP-binding domain.47 Curiously, the native M. tuber-
culosis Hsp70 does not stimulate IL-12 synthesis by THP1 mono-
cytes46 but the C-terminal domain does, suggesting that some form
of proteolysis of Hsp70 is required to generate IL-12 frommonocytes.
Dendritic cells did respond to the native Hsp70.46 In addition to
binding to CD40, further examination of the M. tuberculosis Hsp70
revealed that it also bound to the HIV co-receptor and chemokine
receptor CCR5.48,49 Using inhibitors of CD40 and CCR5 revealed thatboth receptors are involved in the Hsp70 stimulation of dendritic
cells.48 As HIV and M. tuberculosis Hsp70 both bind to CCR5, could
the latter prevent the former binding to CD4 T lymphocytes? Indeed,
both the nativeM. tuberculosisHsp70 and a peptide epitope 407e426
were able to dose-dependently inhibit binding of HIV to CD4 T
lymphocytes, thus suggesting that this mycobacterial protein could
have therapeutic properties.50 It is also interesting in light of the
known association between infection with HIV and M. tuberculosis.
Before leaving this subject of Hsp70 signalling to monocytes it is
worth noting that the human monocyte receptor for lipopolysac-
charide contains human Hsp70 and Hsp90 revealing an interesting
moonlighting activity of these human proteins.51
Widening the moonlighting actions of M. tuberculosis Hsp70 is
the report that it also binds to plasminogen, although the role that
this binding could play is not yet known.52
1. Conclusions
It is becoming clear that we still understand little about the
chaperonins of the mycobacteria. Thus the recently described groE
promoter which regulates expression of Cpn10 and Cpn60.1 in
M. tuberculosis andM. smegmatis is claimed to be more active in the
latter organism than the groEL2 promoter which controls Cpn60.2
transcription.53 This did not appear to be the case in M. tubercu-
losis.2 It has recently been reported that M. tuberculosis Cpn60.1 is
phosphorylated on residues Thr25 and Thr54 by the serine/threo-
nine protein kinase, PknF. In contrast, the M. smegmatis Cpn60.1 is
not phosphorylated by its cognate PknF.54 The role of such phos-
phorylation on the biological actions, including the moonlighting
actions, of M. tuberculosis Cpn60.1 needs to be deﬁned. The
potential importance of the phosphorylation of the mycobacterial
chaperonins is further emphasised by the report that double ring
formation in M. tuberculosis Cpn60.1 is dependent upon phos-
phorylation at Ser393.55 Thus not only are themoonlighting actions
of the mycobacterial chaperonins unclear, even their biochemical/
mechanistic actions are unexpected.
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proteins including molecular chaperones, protein folding catalysts
and redox-active proteins. It is clear that the major molecular
chaperones such as Cpn10, Cpn60.1, Cpn60.2, Hsp70 and the small
heat shock proteins have important moonlighting functions both at
the cell surface and as secreted proteins and are clearly participants
in the disease processes induced by infection with M. tuberculosis.
An important question that has not been addressed is whether
these various cell stress proteins interact to generate emergent
properties. Thus these proteins could show antagonism, synergy or
somemore complex interactional behaviour. The functions of these
knownmoonlighting molecular chaperones and cell stress proteins
need to be examined in more detail and all other similar proteins in
the mycobacteria should be analysed for moonlighting activity. The
evidence at the present time points to these proteins being
potential therapeutic targets for the treatment of tuberculosis.
Furthermore the ability of M. tuberculosis Cpn60.1 to inhibit oste-
oclast formation by inhibiting NFATc1, but not NF-kB21, could have
important therapeutic consequences for diseases such as rheuma-
toid arthritis and osteoporosis where osteoclast over-production
causes pathology. Finally, a very early report revealed that cultured
macrophage tumour cells (J774) transfected with the gene encod-
ingM. tuberculosis Cpn60.2 lost their ability to form tumours.56 This
was suggested to be due to increased immunological recognition of
the tumour cells, but with our increased understanding of the
moonlighting actions of this protein other explanations may be
likely.
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